Lexaria Bioscience Stock (NASDAQ:LEXX), Quotes and News Summary

Q: What sector and industry does Lexaria Bioscience (LEXX) operate in?

Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Lexaria Bioscience Stock (NASDAQ: LEXX) stock price, news, charts, stock research, profile.

Open	$2.150
Close	-
Volume / Avg.	2.810K / 482.133K
Day Range	2.150 - 2.228
52 Wk Range	0.649 - 6.850
Market Cap	$27.891M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	37
Short Interest	4%
Days to Cover	1

Recent News

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Avi Kapoor

Why Lexaria Bioscience (LEXX) Shares Are Moving

Lexaria Bioscience shares are trading lower by 6.5% Thursday morning. The company finalized agreements for a registered direct offering.

Henry Khederian

Lexaria's Formulated Cannabidiol Showed Reduction In Pro-Inflammatory Biomarkers Associated with Heart Diseases

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Lexaria Bioscience Corp

Sector

Health Care

Industry

Pharmaceuticals

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pha...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lexaria Bioscience (LEXX) stock?

You can purchase shares of Lexaria Bioscience (NASDAQ: LEXX) through any online brokerage.

View our list of the best stock brokerages.

Who are Lexaria Bioscience's (LEXX) competitors?

Other companies in Lexaria Bioscience’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), SCYNEXIS (NASDAQ:SCYX) and CalciMedica (NASDAQ:CALC).

What is the target price for Lexaria Bioscience (LEXX) stock?

The latest price target for Lexaria Bioscience (NASDAQ: LEXX) was reported by Maxim Group on Tuesday, March 5, 2024. The analyst firm set a price target for 12.00 expecting LEXX to rise to within 12 months (a possible 452.31% upside). 2 analyst firms have reported ratings in the last year.

Current Stock Price for Lexaria Bioscience (LEXX)?

The stock price for Lexaria Bioscience (NASDAQ: LEXX) is $2.1727 last updated Today at April 25, 2024 at 10:05 AM EDT.

Does Lexaria Bioscience (LEXX) pay a dividend?

There are no upcoming dividends for Lexaria Bioscience.

When is Lexaria Bioscience (NASDAQ:LEXX) reporting earnings?

Lexaria Bioscience’s Q3 earnings are confirmed for Friday, July 12, 2024.

Is Lexaria Bioscience (LEXX) going to split?

There is no upcoming split for Lexaria Bioscience.

What sector and industry does Lexaria Bioscience (LEXX) operate in?

Lexaria Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-